Exelixis
EXEL
#1787
Rank
A$16.62 B
Marketcap
A$61.99
Share price
0.23%
Change (1 day)
8.12%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company